AZD4573

≥99%

  • Product Code: 99679
  CAS:    2057509-72-3
Molecular Weight: 429.94 g./mol Molecular Formula: C₂₂H₂₈ClN₅O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: AZD4573 is primarily investigated for its potential in cancer therapy, particularly in targeting hematologic malignancies. It functions as a selective inhibitor of cyclin-dependent kinases (CDKs), which play a crucial role in cell cycle regulation. By inhibiting these kinases, AZD4573 aims to disrupt the proliferation of cancer cells, leading to their apoptosis. This makes it a promising candidate for treating cancers like leukemia and lymphoma, where uncontrolled cell division is a hallmark. Ongoing clinical trials are evaluating its efficacy, safety, and optimal dosing regimens in patients with advanced or refractory blood cancers.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days $837.62
+
-
0.010 10-20 days $1,300.72
+
-
AZD4573
AZD4573 is primarily investigated for its potential in cancer therapy, particularly in targeting hematologic malignancies. It functions as a selective inhibitor of cyclin-dependent kinases (CDKs), which play a crucial role in cell cycle regulation. By inhibiting these kinases, AZD4573 aims to disrupt the proliferation of cancer cells, leading to their apoptosis. This makes it a promising candidate for treating cancers like leukemia and lymphoma, where uncontrolled cell division is a hallmark. Ongoing clinical trials are evaluating its efficacy, safety, and optimal dosing regimens in patients with advanced or refractory blood cancers.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :